Off-patent industry association Medicines for Ireland has announced a new leadership team amid negotiations on a new local pricing agreement. Meanwhile, UK body the BGMA has named a new vice-chair. And active pharmaceutical ingredients firm EuroAPI has made two additions to its executive committee following the recent departure of its CEO.
Irish off-patent industry association Medicines for Ireland has appointed a new chair and vice-chair, as the association prepares for the negotiation of a new national pricing agreement with the country’s government.
Paul Neill, director of generic medicines for Teva Pharmaceuticals Ireland, will be the new chairperson of MFI; while Melissa Fisher,...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
